$ACST - 1.618 Extention Target Inbound Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada. SHORT INTEREST 1.21M 09/30/19 P/E Current -3.01 P/E Ratio (with extraordinary items) -4.02 Average Recommendation: BUY Average Target Price: 5.31 Longby DEXWireNews14
Golden Cross on All EMAs Into an UptrendCould be a big run. Looks like this stock is running cycles. There is also a chance it could fall flat. Wait for confirmation.Longby stockSpin2
$ACST Fibonacci Levels Get A Close LookWe first recommended $ACST to our subscribers when it was trading at $1.01 a share. Many missed the exit and are still asking what levels to trade $ACST off of. The fibonacci retracement levels provide a good indicator to go off. Good luck to all!by InsiderFinancial11
ACST - Bounce ? ACST - heavy resistance at 1.16 will be watching for a beat high of day if this reaches 1.33 will possibly get in long, but if this shorts will be looking for a bounce or a short if this tries to match 1.33 hod by kiwiktrader0
ACASTI PHARMA INC - NASDAQ: $ACST Picking Its Head UpSince breaking-out last October'18, ACASTI PHARMA INC - NASDAQ:ACST has been trading in a side-ways grind with no real progress towards higher levels to speak of. However, we've been monitoring the action closely for some time now and it appears that ACST may just be starting to pick its head up as evidenced in the Daily chart above. With the stock trading above all of its important moving averages 20/50/200 DMA's, the technical picture remains favorable despite the lack of upside progress over the past 8-9 months. While ACST requires further work, both investors/traders may want to continue to monitor the action closely in the days/weeks ahead. In particular, should ACST be capable of clearing the $1.15 hurdle, such development may just ignite the stock and finally break free from its long slumber. Thus, both investors/traders may want to put ACST front-and-center on their radars.by InsiderFinancial6
ACSTACST broke upward passed our MA, it is between a major support and resistance line. Way to early to call a buy or sell. the next few days will be key. if says above the support we will take a position and target 5% easy by MJKelleyII2
Fish oils will squeeze all shortsThat is a very risky play but with all shorts covering up we can go to 3$.Longby tylenisbobas1
ACST 90-160% PROFIT -911Fib time zones align -#connect4 major- bounce later minor(dead-bounce-fall--*bounce) pattern made@ \90,120,160--=90 drop with another 90 bounce/160, $precidtionLongby djays1.6181
ACST at bottom, nice closing above 1downtrend seems to be over, watch for breakout TP to 1.15, even more possible if volume kicks inLongby meitshelUpdated 1
$acst Looking good over 1.15 ideaNo Position until it closes the gap and stays over $1.15by SwingingForward1